Evidence Generation to Support Novel Biomarker Access Strategy: A Case Study
Time: 11:30 am
day: Conference Day One - Track 2
Details:
- Demonstrating the true frequency of the novel biomarker in the patient population and which diagnostic method is most appropriate to optimize detection
- Identifying the barriers to patients getting appropriate testing and evidence generation to support improved access
- Exploring how Precision Medicine stakeholders are working together to address diagnostic access barriers
